- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/53 - Colony-stimulating factor [CSF]
Patent holdings for IPC class C07K 14/53
Total number of patents in this class: 85
10-year publication summary
5
|
6
|
3
|
8
|
7
|
8
|
5
|
4
|
6
|
4
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
King's College London | 530 |
8 |
Shattuck Labs, Inc. | 119 |
5 |
Novartis Vaccines and Diagnostics, Inc. (a Delaware corporation) | 37 |
2 |
The Regents of the University of California | 19839 |
2 |
The Trustees of the University of Pennsylvania | 4315 |
2 |
B.G. Negev Technologies and Applications Ltd., at Ben-gurion University | 349 |
2 |
The Governing Council of The University of Toronto, | 1466 |
2 |
Hanmi Science Co., Ltd. | 133 |
2 |
Icahn School of Medicine at Mount Sinai | 936 |
2 |
Les Hopitaux Universitaires de Geneve | 40 |
2 |
Memorial Sloan-Kettering Cancer Center | 1913 |
2 |
The National Institute for Biotechnology in The Negev Ltd. | 105 |
2 |
New York University | 1734 |
2 |
The Scripps Research Institute | 1346 |
2 |
Universite de Geneve | 230 |
2 |
The Wistar Institute of Anatomy and Biology | 447 |
2 |
XOMA Technology Ltd. | 70 |
2 |
Synlogic Operating Company, Inc. | 114 |
2 |
Hunan Siweikang Therapeutics Co. Ltd | 3 |
2 |
Wyeth LLC | 653 |
1 |
Other owners | 37 |